Physician

Brian Andrew O'Neal, D.O. , MPH

According to 2025 Medicare claims, Brian O'Neal, D.O. , MPH (NPI: 1639159494) practices dermatology in the Johnson City, TN market, with the plurality of this provider's patient population coming from Washington, TN. This provider's primary affiliated billing organization is DERMATOLOGY ASSOCIATES, P.C. (NPI: 1487695862; TIN: 62-1013399) and primary practice location at 37615-8002. O'Neal is affiliated with the Sharp Rees-Stealy Medical Group (ACO ID: A5521), participating under the MSSP model.

O'Neal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 783 traditional Medicare patients, billed 4,910 HCPCS/CPT codes, and received $185,597 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,349 prescription claims across 696 beneficiaries totaling $891,370 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 9 records totaling $342. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $18,788 to $185,597. Similarly, Part D prescription costs have risen steadily, from $7,840 to $891,370. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	99	420	$18,788
2019	256	1,877	$77,938
2020	272	1,629	$77,412
2021	242	1,582	$74,897
2022	735	3,933	$151,418
2023	861	6,065	$209,668
2024	783	4,910	$185,597

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	83	135	$7,840
2019	243	499	$51,456
2020	214	429	$41,824
2021	222	489	$125,989
2022	383	617	$181,515
2023	675	1,212	$516,968
2024	696	1,349	$891,370

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	237	261	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	395	471	$58
17000	Destruction of precancer skin growth, 1 growth	430	526	$35
88305	Pathology examination of tissue using a microscope, intermediate complexity	301	538	$26
17003	Destruction of precancer skin growth, 2-14 growths	327	1,925	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	16	1,232	$335,604
Dupixent Pen	Dupilumab	27	729	$103,283
Otezla	Apremilast	13	390	$64,593
Fluorouracil	Fluorouracil	82	2,419	$6,686
Betamethasone Dipropionate	Betamethasone Dipropionate	92	2,294	$4,729

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$342	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian Andrew O'Neal, D.O. , MPH?

Tedicare shows public-source Medicare data for Brian Andrew O'Neal, D.O. , MPH (NPI 1639159494), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Andrew O'Neal, D.O. , MPH have ACO affiliation data?

Brian Andrew O'Neal, D.O. , MPH is shown with ACO affiliation data for Sharp Rees-Stealy Medical Group (MSSP, ACO ID A5521).

What billing organization is linked to Brian Andrew O'Neal, D.O. , MPH?

Brian Andrew O'Neal, D.O. , MPH is linked to DERMATOLOGY ASSOCIATES, P.C. (billing NPI 1487695862) in the available physician profile data.

Does Brian Andrew O'Neal, D.O. , MPH have Open Payments data?

Brian Andrew O'Neal, D.O. , MPH has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.